Figure 5:
Comparison of IL-1 (A), IL-6 (B) and IL-10 (C) production in PBMC isolated from subjects receiving BIM product and placebo (n=5) upon TCR activation.
Figure 6:
Comparison of IL-17 (A) and IL-22 (B) production in PBMC isolated from subjects receiving BIM product and placebo (n=5) upon TCR activation.
|